Sec. 7. (a) A research institution in Indiana may apply to the division to receive financial assistance from the fund to conduct one (1) or more clinical studies to evaluate the efficacy of psilocybin as an alternative treatment for mental health and other medical conditions, including the following:

(1) Posttraumatic stress disorder, with a focus on treating the disorder in combat veterans and first responders.

lawyer at desk

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

Terms Used In Indiana Code 12-21-9-7

  • fund: refers to the therapeutic psilocybin research fund established by section 4 of this chapter. See Indiana Code 12-21-9-1
  • psilocybin: means a naturally occurring psychedelic prodrug compound that is produced by fungi, including members of the genus psilocybe. See Indiana Code 12-21-9-2
  • research institution: refers to an organization that meets all of the following:

    Indiana Code 12-21-9-3

(2) Anxiety.

(3) Depression.

(4) Bipolar disorder.

(5) Chronic pain.

(6) Migraines.

(7) Alcohol use disorder.

(8) Tobacco use disorder.

     (b) In conducting a clinical study under this section, a research institution that receives a grant under this chapter shall do the following:

(1) Include veterans and first responders in the study sample.

(2) Evaluate and determine whether psilocybin is an effective treatment for mental health and other medical conditions described in subsection (a).

(3) Compare the efficacy of psilocybin as a treatment for mental health and other medical conditions described in subsection (a) with the efficacy of other current treatment options for mental health and other medical conditions described in subsection (a).

(4) Before entering the study, require each participant to undergo a mental health evaluation.

As added by P.L.152-2024, SEC.4.

  Previous section
Next section  
 Chapter 9 Contents